Accessorize At Your Own Risk: Draft Guidance Clarifies Regs For Device Add-Ons
This article was originally published in The Gray Sheet
Executive Summary
FDA says it will classify risk for accessories separate from a parent medical device, which could reduce requirements in some cases, but may call for more proactive regulatory efforts by companies, experts suggest.